Wealth Enhancement Advisory Services, LLC Editas Medicine, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 18,416 shares of EDIT stock, worth $24,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,416Holding current value
$24,124% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
228Shares Held
54.2MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$10.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$8.94 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$3.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$2.83 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$2.45 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $90M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...